Covid-19
Conditions
Interventions
Nirmatrelvir/ Ritonavir group:NA
Molnupiravir group:NA
Azvudine group:NA
Control group:NA
Sponsors
Beijing Chaoyang Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Confirmed diagnosis of novel coronavirus infection. All patients admitted due to COVID-19 should be included in the study screening. Patients aged over 18 years who are confirmed to have SARS-CoV-2 infection by rapid antigen testing or RT-PCR test upon admission. Patients who receive antiviral treatments such as Nirmatrelvir/Ritonavir, Molnupiravir and Azvudine during hospitalization, or have not received any antiviral drugs. Presence of at least one high-risk factor (age = 60 years; presence of diabetes, hypertension, cardiovascular disease, chronic pulmonary disease, stroke, chronic liver or kidney disease, cancer, history of smoking, or obesity).
Exclusion criteria
Exclusion criteria: Exclusion Criteria: Death within 24 hours of hospital admission. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Invasive mechanical ventilation event rates;Intensive care unit event rates;Inpatient duration;Clinical disease progression rate; | — |
Countries
China
Contacts
Public ContactZhaohui Tong,Zhuoling An
Beijing Chaoyang Hospital Affiliated to Capital Medical University
Outcome results
None listed